MEDICINA PREVENTIVA Y SALUD PÚBLICA
Departamento
Stanisław Sław S.
Gõźdź
Publicaciones en las que colabora con Stanisław Sław S. Gõźdź (53)
2021
-
The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3)
Neuro-Oncology, Vol. 23, Núm. 10, pp. 1765-1776
2020
-
Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study
Breast Cancer Research and Treatment, Vol. 183, Núm. 2, pp. 439-450
-
Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study
Archives of Gynecology and Obstetrics, Vol. 301, Núm. 2, pp. 591-602
2019
-
Epidemiology of rare cancers and inequalities in oncologic outcomes
European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 3-11
-
Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting
European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 75-80
-
Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference
European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 60-66
-
Treatment challenges in and outside a network setting: Head and neck cancers
European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 40-45
-
Treatment challenges in and outside a network setting: Soft tissue sarcomas
European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 31-39
-
Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours
European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 46-51
2018
2017
-
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study
The Lancet Oncology, Vol. 18, Núm. 8, pp. 1022-1039
-
Data quality in rare cancers registraton: The report of the RARECARE data quality study
Tumori, Vol. 103, Núm. 1, pp. 22-32
-
Erratum to “The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 405–413](S0090825816314974)(10.1016/j.ygyno.2016.10.019)
Gynecologic Oncology
-
Erratum to “Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 396–404](S009082581631575X)(10.1016/j.ygyno.2016.11.019)
Gynecologic Oncology
-
Geographical variability in survival of European children with central nervous system tumours
European Journal of Cancer, Vol. 82, pp. 137-148
-
Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study
European Journal of Cancer, Vol. 84, pp. 335-353
-
Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5
European Journal of Cancer, Vol. 77, pp. 140-152
-
The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2)
Gynecologic Oncology, Vol. 144, Núm. 2, pp. 405-413
-
Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)
Gynecologic Oncology, Vol. 144, Núm. 2, pp. 396-404
-
Worldwide comparison of survival from childhood leukaemia for 1995–2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries
The Lancet Haematology, Vol. 4, Núm. 5, pp. e202-e217